2024
|
Invention
|
Prodrugs of tetrahydrocannabinol compositions comprising prodrugs of tetrahydrocannabinol and met... |
|
Invention
|
Treatment of irritability in subjects with autism spectrum disorders with moderate to severe anxi... |
2023
|
Invention
|
Treatment of fragile x syndrome with cannabidiol.
The present technology relates to a method of ... |
|
G/S
|
Pharmaceutical preparations for the treatment of human and veterinary diseases and disorders, nam... |
|
Invention
|
Methods of treatment of osteoarthritis with transdermal cannabidiol gel.
A pharmaceutical compos... |
2022
|
Invention
|
Treatment of 22q11.2 deletion syndrome with cannabidiol.
The present technology relates to metho... |
|
Invention
|
Treatment of fragile x syndrome with cannabidiol. The present technology relates to a method of t... |
|
Invention
|
Treatment of behavioral impairment in developmental and epileptic encephalopathy.
The present te... |
|
Invention
|
Treatment of sleep apnea with cbd.
Provided are methods of treating sleep disorders in patients ... |
|
Invention
|
Treatment of sleep apnea with cbd. Provided are methods of treating sleep disorders in patients b... |
2021
|
Invention
|
Cannabidiol for the treatment of refractory seizures.
Provided are methods of treating refractor... |
|
Invention
|
Cannabidiol for the treatment of refractory seizures. Provided are methods of treating refractory... |
|
Invention
|
Treatment of refractory seizures. Provided are methods of treating refractory seizures in a human... |
|
Invention
|
Prodrugs of tetrahydrocannabinol, compositions comprising prodrugs of tetrahydrocannabinol and me... |
|
Invention
|
Treatment of autism with cannabidiol.
The present technology relates to a method of treating one... |
|
Invention
|
Treatment of autism spectrum disorder with cannabidiol. The present technology relates to a metho... |
|
Invention
|
Treatment of fragile x syndrome and autism spectrum disorder with cannabidiol.
The present techn... |
2020
|
Invention
|
Treatment of behavioral impairment in developmental and epileptic encephalopathy. The present tec... |
|
Invention
|
Treatment of syngap1 encephalopathy. The present technology relates to methods of treating SYNGAP... |
|
Invention
|
Treatment of syngap1 encephalopathy.
The present technology relates to methods of treating SYNGA... |
|
Invention
|
Synthetic transdermal cannabidiol for the treatment of focal epilepsy in adults.
The present tec... |
2019
|
Invention
|
Treatment of 22q11.2 deletion syndrome with cannabidiol. The present technology relates to method... |
|
Invention
|
Treatment of autism with cannabidiol. The present technology relates to a method of treating one ... |
2018
|
Invention
|
Use of cannabidiol prodrugs in pharmaceutical compositions. Described herein are cannabidiol prod... |
2014
|
G/S
|
Pharmaceutical and therapeutic drug development services; pharmaceutical and therapeutic drug res... |